BioAtla Garners $45,000,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d030d2a2-93e9-4b89-9441-4c7ada9d0e90 - Date
1/11/2016 - Company Name
BioAtla - Mailing Address
11011 Torreyana Road San Diego, CA 92121 USA - Company Description
BioAtla uses deep expertise in protein and antibody engineering and proprietary technologies to solve critical protein development challenges and produce novel, IP-protectable products for our partners and our own product portfolio. - Website
http://www.bioatla.com - Transaction Type
Debt - Transaction Amount
$45,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Through the program funding, Global BIO will share in the risks and the potential returns of BioAtla’s first four CAB candidates that receive Investigational New Drug (IND) approval by the U.S. Food and Drug Administration. - M&A Terms
- Venture Investor
Global BIO Impact Fund
